HUMANIFESTO Trademark

Trademark Overview


On Wednesday, December 4, 2013, a trademark application was filed for HUMANIFESTO with the United States Patent and Trademark Office. The USPTO has given the HUMANIFESTO trademark a serial number of 86134912. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 17, 2022. This trademark is owned by Celgene Corporation. The HUMANIFESTO trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical information services, namely, collecting, analyzing, reporting, and providing feedback focused on cancer patients

research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services
humanifesto

General Information


Serial Number86134912
Word MarkHUMANIFESTO
Filing DateWednesday, December 4, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 17, 2022
Registration Number4861748
Registration DateTuesday, December 1, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements


Goods and ServicesMedical information services, namely, collecting, analyzing, reporting, and providing feedback focused on cancer patients
Goods and Servicesresearch in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 17, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Saturday, December 7, 2013NEW APPLICATION ENTERED
Monday, December 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 26, 2014ASSIGNED TO EXAMINER
Friday, May 9, 2014SUSPENSION LETTER WRITTEN
Friday, February 28, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, March 5, 2014NON-FINAL ACTION WRITTEN
Wednesday, March 5, 2014NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 25, 2014ASSIGNED TO LIE
Thursday, April 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 9, 2014LETTER OF SUSPENSION E-MAILED
Friday, May 9, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 13, 2014SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, January 6, 2015ASSIGNED TO EXAMINER
Tuesday, January 6, 2015NON-FINAL ACTION WRITTEN
Tuesday, January 6, 2015NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 16, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 27, 2015CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 16, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, July 16, 2015NOTICE OF ALLOWANCE CANCELLED
Sunday, August 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 28, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, December 1, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, December 1, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 17, 2022CANCELLED SEC. 8 (6-YR)